nisoldipine has been researched along with Aura in 2 studies
Nisoldipine: A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.
nisoldipine : A racemate consisting of equimolar amounts of (R)- and (S)-nisoldipine. A calcium channel blocker, it is used in the treatment of hypertension and angina pectoris.
methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a methoxycarbonyl group at position 3, an o-nitrophenyl group at position 4, and an isobutoxycarbonyl group at position 5. The racemate, a calcium channel blocker, is used in the treatment of hypertension and angina pectoris.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twelve patients with epilepsy receiving chronic phenytoin therapy and 12 healthy control subjects matched for age and gender received a single oral dose of nisoldipine (40 and 20 mg, respectively)." | 7.69 | Reduced plasma nisoldipine concentrations in phenytoin-treated patients with epilepsy. ( Cipolla, G; Gatti, G; Heinig, R; Michelucci, R; Ochan, M; Passarelli, D; Perucca, E; Tassinari, CA, 1996) |
| "Twelve patients with epilepsy receiving chronic phenytoin therapy and 12 healthy control subjects matched for age and gender received a single oral dose of nisoldipine (40 and 20 mg, respectively)." | 3.69 | Reduced plasma nisoldipine concentrations in phenytoin-treated patients with epilepsy. ( Cipolla, G; Gatti, G; Heinig, R; Michelucci, R; Ochan, M; Passarelli, D; Perucca, E; Tassinari, CA, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doyle, KM | 1 |
| Kirby, BP | 1 |
| Murphy, D | 1 |
| Shaw, GG | 1 |
| Michelucci, R | 1 |
| Cipolla, G | 1 |
| Passarelli, D | 1 |
| Gatti, G | 1 |
| Ochan, M | 1 |
| Heinig, R | 1 |
| Tassinari, CA | 1 |
| Perucca, E | 1 |
2 other studies available for nisoldipine and Aura
| Article | Year |
|---|---|
Effect of L-type calcium channel antagonists on spermine-induced CNS excitation in vivo.
Topics: Amines; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Central Nervous System; Convuls | 2005 |
Reduced plasma nisoldipine concentrations in phenytoin-treated patients with epilepsy.
Topics: Adult; Contraindications; Delayed-Action Preparations; Drug Interactions; Epilepsy; Female; Humans; | 1996 |